Health Care Down on Regulatory Concerns -- Health Care Roundup

AstraZeneca to invest $2 billion in the U.S. post Trump's win. Amedisys stock drops due to UnitedHealth acquisition lawsuit. Johnson & Johnson challenges federal health agency. Novavax shares fall despite revenue beat.